California Public Employees Retirement System reduced its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 2.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 69,548 shares of the company’s stock after selling 1,438 shares during the period. California Public Employees Retirement System owned approximately 0.46% of Chemed worth $36,847,000 as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in Chemed in the 4th quarter valued at $42,023,000. HighTower Advisors LLC grew its holdings in shares of Chemed by 78.0% in the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock valued at $2,246,000 after acquiring an additional 1,634 shares in the last quarter. XTX Topco Ltd raised its holdings in Chemed by 111.5% during the third quarter. XTX Topco Ltd now owns 2,843 shares of the company’s stock worth $1,709,000 after acquiring an additional 1,499 shares in the last quarter. Geode Capital Management LLC raised its holdings in Chemed by 4.9% during the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock worth $201,820,000 after acquiring an additional 15,791 shares in the last quarter. Finally, Signal Advisors Wealth LLC boosted its position in Chemed by 60.7% during the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock valued at $2,647,000 after purchasing an additional 1,886 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.
Insider Buying and Selling at Chemed
In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 3.32% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on Chemed
Chemed Stock Down 0.7 %
Shares of NYSE CHE opened at $614.41 on Thursday. The business’s 50 day moving average price is $577.76 and its two-hundred day moving average price is $567.62. The company has a market cap of $8.99 billion, a PE ratio of 31.05, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $639.61.
Chemed Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio (DPR) is presently 10.05%.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
- Five stocks we like better than Chemed
- Using the MarketBeat Stock Split Calculator
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Investing in Commodities: What Are They? How to Invest in Them
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.